AstraZeneca
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has AstraZeneca's balance sheet done over the years? Its assets were worth $101,119,000,000 last year, which is more than in the previous period. 61% of AstraZeneca’s total assets is currently financed by debt. Its liabilities reached the amount of $61,953,000,000, which means an increase by 4% compared compared to last year.
Debt to Assets
| 2014 | 58595000000 | 38.94B | 66.47% |
|---|---|---|---|
| 2015 | 60124000000 | 41.61B | 69.22% |
| 2016 | 62526000000 | 45.85B | 73.34% |
| 2017 | 63354000000 | 46.71B | 73.73% |
| 2018 | 60651000000 | 46.60B | 76.84% |
| 2019 | 61377000000 | 46.78B | 76.22% |
| 2020 | 66729000000 | 51.09B | 76.56% |
| 2021 | 105363000000 | 66.07B | 62.71% |
| 2022 | 96483000000 | 59.42B | 61.59% |
| 2023 | 101119000000 | 61.95B | 61.27% |
AZN Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 5.84B | 6.16B | 6.32B | 7.83B | 5.36B | 4.83B | 3.32B | 5.01B | 6.24B | 6.36B |
Short term investments | 20M | 239M | 69M | 160M | 849M | 849M | 1.23B | 884M | 613M | 795M |
Net receivables | 8.40B | 9.92B | 10.75B | 5.65B | 5.18B | -86M | 2.80B | -91M | 7.00B | 7.56B |
Inventory | 5.42B | 4.69B | 8.98B | 4.02B | 3.19B | 2.89B | 3.03B | 2.33B | 2.14B | 1.96B |
Other current assets | 5.36B | 11.48B | 105M | 1.87B | 971M | 7.10B | 2.75B | 5.11B | 2.37B | 3.59B |
Total current assets | 25.05B | 22.59B | 26.24B | 19.54B | 15.56B | 15.59B | 13.15B | 13.26B | 16.00B | 16.69B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 10.50B | 9.44B | 10.17B | 8.91B | 8.33B | 7.42B | 7.61B | 6.84B | 6.41B | 6.01B |
Goodwill | 20.04B | 19.82B | 19.99B | 11.84B | 11.66B | 11.70B | 11.82B | 11.65B | 11.86B | 11.55B |
Intangible assets | 38.08B | 39.30B | 42.38B | 20.94B | 20.83B | 21.95B | 26.18B | 27.58B | 22.64B | 20.98B |
Long term investments | 1.77B | 903M | 1.16B | 987M | 610M | 73M | -194M | -58M | -70M | -234M |
Other non-current assets | 931M | 1.14B | 1.06B | 1.05B | 1.65B | 1.52B | 2.58B | 2.12B | 1.96B | 2.37B |
Total non-current assets | 76.06B | 73.89B | 79.11B | 47.18B | 45.81B | 45.06B | 50.20B | 49.26B | 44.11B | 41.89B |
Total assets | 101.11B | 96.48B | 105.36B | 66.72B | 61.37B | 60.65B | 63.35B | 62.52B | 60.12B | 58.59B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 149M | 181M | 1.01B | 1.62B | 28M | -11.12B | -8.03B | -7.49B | -8.19B | -8.39B |
Short term debt | 6.38B | 5.54B | 1.89B | 2.38B | 2.01B | 1.75B | 2.27B | 2.30B | 925M | 2.46B |
Total current liabilities | 30.54B | 26.29B | 22.59B | 20.30B | 18.11B | 16.29B | 16.38B | 15.25B | 14.86B | 17.33B |
| Non-current liabilities: | ||||||||||
Long term debt | 23.22B | 23.69B | 28.88B | 17.99B | 16.21B | 17.35B | 15.56B | 14.50B | 14.13B | 8.39B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 5.33B | 6.48B | 8.36B | 9.83B | 9.90B | 9.59B | 10.77B | 25.30B | 12.54B | 11.42B |
Total non-current liabilities | 31.41B | 33.13B | 43.48B | 30.78B | 28.66B | 30.31B | 30.32B | 30.60B | 26.74B | 21.61B |
Total liabilities | 61.95B | 59.42B | 66.07B | 51.09B | 46.78B | 46.60B | 46.71B | 45.85B | 41.61B | 38.94B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |